27.73
price up icon2.78%   0.75
after-market アフターアワーズ: 27.90 0.17 +0.61%
loading
前日終値:
$26.98
開ける:
$27.11
24時間の取引高:
789.87K
Relative Volume:
1.16
時価総額:
$2.06B
収益:
$105.97M
当期純損益:
$-81.13M
株価収益率:
-25.70
EPS:
-1.0791
ネットキャッシュフロー:
$-35.43M
1週間 パフォーマンス:
+3.82%
1か月 パフォーマンス:
+21.20%
6か月 パフォーマンス:
+48.93%
1年 パフォーマンス:
+153.47%
1日の値動き範囲:
Value
$26.91
$27.92
1週間の範囲:
Value
$25.83
$27.92
52週間の値動き範囲:
Value
$10.69
$28.49

Zymeworks Inc. Stock (ZYME) Company Profile

Name
名前
Zymeworks Inc.
Name
セクター
Healthcare (1112)
Name
電話
604-678-1388
Name
住所
1385 West 8th Avenue, Suite 540, Vancouver, BC
Name
職員
170
Name
Twitter
@ZymeworksInc
Name
次回の収益日
2026-03-02
Name
最新のSEC提出書
Name
ZYME's Discussions on Twitter

Compare ZYME vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ZYME icon
ZYME
Zymeworks Inc.
27.73 2.00B 105.97M -81.13M -35.43M -1.0791
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
441.70 113.01B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
753.93 79.87B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
840.87 51.51B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
333.39 45.29B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
319.94 34.41B 5.36B 287.73M 924.18M 2.5229

Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-12 アップグレード Wells Fargo Equal Weight → Overweight
2025-12-03 開始されました Citizens JMP Mkt Outperform
2025-10-24 再開されました Wells Fargo Equal Weight
2025-10-14 アップグレード H.C. Wainwright Neutral → Buy
2025-10-10 開始されました B. Riley Securities Buy
2025-05-20 開始されました TD Cowen Buy
2024-12-16 アップグレード JP Morgan Neutral → Overweight
2024-11-07 アップグレード Leerink Partners Market Perform → Outperform
2024-11-01 ダウングレード Wells Fargo Overweight → Equal Weight
2023-03-21 再開されました Wells Fargo Overweight
2023-01-04 繰り返されました H.C. Wainwright Neutral
2022-12-20 アップグレード Jefferies Hold → Buy
2022-11-01 ダウングレード H.C. Wainwright Buy → Neutral
2022-10-21 ダウングレード SVB Leerink Outperform → Mkt Perform
2022-10-04 再開されました Wells Fargo Overweight
2022-05-05 アップグレード Guggenheim Neutral → Buy
2022-03-15 開始されました Evercore ISI Outperform
2021-12-10 アップグレード SVB Leerink Mkt Perform → Outperform
2021-11-17 再開されました Guggenheim Neutral
2021-10-07 開始されました Jefferies Hold
2021-03-31 開始されました Credit Suisse Outperform
2021-02-25 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-02-08 再開されました H.C. Wainwright Buy
2021-01-25 ダウングレード Citigroup Buy → Neutral
2020-09-29 再開されました JP Morgan Neutral
2020-08-06 開始されました SVB Leerink Outperform
2020-01-10 開始されました Wolfe Research Outperform
2019-12-09 開始されました JP Morgan Neutral
2019-11-25 開始されました H.C. Wainwright Buy
2019-11-20 開始されました Guggenheim Buy
2019-09-30 アップグレード Raymond James Outperform → Strong Buy
2019-08-30 開始されました Stifel Buy
2019-07-18 開始されました Deutsche Bank Buy
2018-05-11 アップグレード Barclays Underweight → Equal Weight
2018-03-19 開始されました Raymond James Outperform
すべてを表示

Zymeworks Inc. (ZYME) 最新ニュース

pulisher
03:57 AM

Zymeworks Inc stock (US98986T1088): Why its biopharma pipeline strategy is suddenly worth a closer l - AD HOC NEWS

03:57 AM
pulisher
05:03 AM

Zymeworks (ZYME) price target increased by 12.53% to 40.88 - MSN

05:03 AM
pulisher
04:56 AM

Zymeworks Inc. (NYSE:ZYME) Q1 2025 Earnings Call Transcript - MSN

04:56 AM
pulisher
Apr 14, 2026

How Investors Are Reacting To Zymeworks (ZYME) Elevating EcoR1 Veterans To Key Executive Roles - simplywall.st

Apr 14, 2026
pulisher
Apr 14, 2026

Zymeworks Inc stock (US98986T1088): Why its biopharma pipeline is suddenly worth a closer look - AD HOC NEWS

Apr 14, 2026
pulisher
Apr 14, 2026

HC Wainwright & Co. Upgrades Zymeworks (ZYME) - MSN

Apr 14, 2026
pulisher
Apr 13, 2026

JPMorgan Chase & Co. Cuts Stock Position in Zymeworks Inc. $ZYME - MarketBeat

Apr 13, 2026
pulisher
Apr 11, 2026

ZYME SEC FilingsZymeworks 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 11, 2026
pulisher
Apr 10, 2026

Zymeworks (NASDAQ: ZYME) awards options, RSUs and PSUs to officer - Stock Titan

Apr 10, 2026
pulisher
Apr 10, 2026

Zymeworks (NASDAQ: ZYME) awards options, RSUs and PSUs to EVP - Stock Titan

Apr 10, 2026
pulisher
Apr 10, 2026

Zymeworks (ZYME) executive reports significant option and RSU awards - Stock Titan

Apr 10, 2026
pulisher
Apr 10, 2026

Zymeworks (ZYME) EVP holds 167,000 options and 111,111 RSUs - Stock Titan

Apr 10, 2026
pulisher
Apr 09, 2026

Zymeworks names Schayowitz as R&D head, Platshon as CBO By Investing.com - Investing.com Australia

Apr 09, 2026
pulisher
Apr 09, 2026

Investment Recap: Should I average down on Zymeworks Inc stock2026 Sector Moves & Verified Momentum Watchlists - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 09, 2026

Zymeworks Inc at JPMorgan Healthcare Conference Transcript - GuruFocus

Apr 09, 2026
pulisher
Apr 09, 2026

Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth - wahanariau.com

Apr 09, 2026
pulisher
Apr 09, 2026

Zymeworks Bolsters Executive Team to Drive Next Phase of Growth - TipRanks

Apr 09, 2026
pulisher
Apr 09, 2026

Zymeworks names Schayowitz as R&D head, Platshon as CBO - Investing.com

Apr 09, 2026
pulisher
Apr 09, 2026

Buybacks Report: Will Zymeworks Inc benefit from geopolitical trends2026 Intraday Action & Weekly Sector Rotation Insights - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 08, 2026

Why Zymeworks (ZYME) Is Up 6.7% After FDA Fast Track Win And CFO Appointment - Sahm

Apr 08, 2026
pulisher
Apr 07, 2026

Zymeworks (NASDAQ: ZYME) grants CFO large option and RSU awards - Stock Titan

Apr 07, 2026
pulisher
Apr 07, 2026

Zymeworks (NASDAQ: ZYME) CFO reports zero beneficial share ownership - Stock Titan

Apr 07, 2026
pulisher
Apr 07, 2026

Short Squeeze: Will Zymeworks Inc benefit from rising consumer demand2026 Macro Moves & Verified Chart Pattern Trade Signals - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 06, 2026

Capricorn Fund Managers Ltd Buys Shares of 1,022,840 Zymeworks Inc. $ZYME - MarketBeat

Apr 06, 2026
pulisher
Apr 06, 2026

A Look At Zymeworks (ZYME) Valuation After Fast Track Win And New CFO Appointment - Sahm

Apr 06, 2026
pulisher
Apr 04, 2026

ZYME PE Ratio & Valuation, Is ZYME Overvalued - Intellectia AI

Apr 04, 2026
pulisher
Apr 04, 2026

ZYME Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026
pulisher
Apr 03, 2026

Zymeworks Inc. R (ZA8.DU) Q1 FY2025 earnings call transcript - Yahoo Finance

Apr 03, 2026
pulisher
Apr 02, 2026

Zymeworks Inc. (ZYME) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 02, 2026
pulisher
Apr 02, 2026

Q3 2025 Zymeworks Inc Earnings Call Transcript - GuruFocus

Apr 02, 2026
pulisher
Apr 02, 2026

Trade Report: How sensitive is Zymeworks Inc to inflationMarket Rally & Capital Efficiency Focused Ideas - baoquankhu1.vn

Apr 02, 2026
pulisher
Apr 02, 2026

ZymeworksLeveraging Partnerships For Value - RTTNews

Apr 02, 2026
pulisher
Apr 02, 2026

Zymeworks appoints Kristin Stafford as chief financial officer By Investing.com - Investing.com South Africa

Apr 02, 2026
pulisher
Apr 02, 2026

Zymeworks Inc. (ZYME) stock price, news, quote and history - Yahoo Finance Singapore

Apr 02, 2026
pulisher
Apr 02, 2026

Trade Recap: Can Zymeworks Inc grow without dilution2026 Movers & Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Apr 02, 2026
pulisher
Apr 01, 2026

Zymeworks appoints Kristin Stafford as CFO - MSN

Apr 01, 2026
pulisher
Apr 01, 2026

Zymeworks Inc. Announces Executive Changes, Effective from April 1, 2026 - marketscreener.com

Apr 01, 2026
pulisher
Apr 01, 2026

Zymeworks Appoints Kristin Stafford as Chief Financial Officer - wahanariau.com

Apr 01, 2026
pulisher
Apr 01, 2026

Zymeworks Names Kristin Stafford as New Chief Financial Officer - TipRanks

Apr 01, 2026
pulisher
Apr 01, 2026

Zymeworks Appoints Kristin Stafford as Chief Financial Officer to Drive Strategic Growth and Value Creation - Minichart

Apr 01, 2026
pulisher
Apr 01, 2026

Zymeworks appoints Kristin Stafford as chief financial officer - Investing.com

Apr 01, 2026
pulisher
Apr 01, 2026

Kristin Stafford named Zymeworks executive VP and CFO as Kenneth Galbraith steps down as interim CFO - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Kristin Stafford joins Zymeworks (Nasdaq: ZYME) as new Chief Financial Officer - Stock Titan

Apr 01, 2026
pulisher
Mar 31, 2026

How Investors May Respond To Zymeworks (ZYME) Fast Track Nod For Ovarian Cancer ADC ZW191 - Yahoo Finance

Mar 31, 2026
pulisher
Mar 31, 2026

FDA grants fast track status to Zymeworks’ ZW191 for ovarian cancer By Investing.com - Investing.com South Africa

Mar 31, 2026
pulisher
Mar 31, 2026

FDA grants fast track status to Zymeworks’ ZW191 for ovarian cancer - Investing.com Australia

Mar 31, 2026
pulisher
Mar 31, 2026

Systematic Evaluation of Maleimide Spacer Impact on Drug-Linker Deconjugation in Antibody-Drug Conjugates Ex Vivo and In Vivo - ACS Publications

Mar 31, 2026
pulisher
Mar 30, 2026

Investment Report: Will Zymeworks Inc benefit from geopolitical trendsPrice Action & Target Return Focused Stock Picks - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

Zymeworks Inc Receives U S Fda Fast Track Designation for Zw191 an Fra Targeting Antibody Drug Conjugate - marketscreener.com

Mar 30, 2026
pulisher
Mar 30, 2026

Zymeworks Wins FDA Fast Track Status for Ovarian Cancer Drug ZW191 - TipRanks

Mar 30, 2026

Zymeworks Inc. (ZYME) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
大文字化:     |  ボリューム (24 時間):